Member Info for Saxondale

Current SP will have no bearing on any offer/license deal .
It may have a bearing if there is a takeover offer , but even then , huge amount of shares are owned by management and Timo , so it won't be a PI capitulation .

The big rerate , as we all know , will come when a deal is announced .
I don't expect that until Q3-Q4 ( Autumn ) , when FDA meetings have decided the Pivotal trial details , and whoever is going to be involved will have agreed terms .

We may get some lesser news in between , such as a Bexmab patient success , or a further biomarker or soluble Clever 1 discovery , along with a new DofD IFN beta trial , and perhaps even Wall St listing .
Who knows , Traumakine may get sold off , now that Faron have such a growing lead candidate .
We were told a month ago that we would be getting some Traumakine news soon.
Also , don't rule out another grant / funding announcement from the EIC or some other group .
Any of these news updates could give us a small boost.
That's why I decided to add to my holding today . I'd rather sit on the shares than try and second guess when the next news is going to land .

You're both still invested here though I guess .So despite being hacked off , you obviously still believe this will come good , otherwise you'd have moved on . Plenty of other discounted shares out there at the moment with massive 'potential ' .
AVCT , even good old SNG going for pennies at the moment .
Today was an update confirming info that already existed , just that it made it to the 12 month period .
Was not groundbreaking - but good foundation going forward .
Still no adverse reactions in all these patients that would affect dosing ( very important for next trial stage )
And excellent performance in survival for responders so far .
And if anybody is hard to keep alive , its refractory cancer patients .

I'm happy enough here . I don't work for Faron . I chucked another £8k in total in here today .
If it all goes down the toilet , that's my fault entirely .

But the CEO is happy to chuck money here too recently .So at sub £2.20 , I call that an opportunity .

On the back of that , in goes another £5k at £2.21.
Surely this should strengthen their hand when discussing the pivotal trials with FDA & potential suitors .

Imagine what the overall benefit rate would have been if they could have selected patients using the low IFN gamma biomarker.
These amazing results have been based on just the patients they have been able to access , not select , as you would if the therapy was on the market .

Can't get better than 100% vs 0% !
And overall 65% for responders vs 11% for non responders ,over the 10 cohorts

No wonder Markku is confident about the next steps .

Well done Faron - making a real difference for patients and families already .

The strongest survival benefit was seen in checkpoint refractory melanoma and cholangiocarcinoma where 12-month survival was 100% among patients who benefited from bexmarilimab treatment and 0% for patients who did not benefit from treatment

Well , I sold a pile of shares on Monday . And just bought the exact number back again now and they cost me a grand less .
Not the way i usually do things , but the SP is just getting daft now , so I thought ' OK , I dare you ' .
Happy days .

Markku bought 25000 shares in April ( about £61k) . He's over £8k down on that purchase alone as of today ( about -14% since April).
He didn't seem overly bothered about that the other day in the interview .
Actually , he seemed very upbeat and excited about what was coming .

Interview wasn't much different from previous one . Just reiterates that patient data won't be long coming through .
And if its positive , and confirms what they saw in the bone marrow samples in the lab , then it will be another major string to Bex's bow , and open up more commercial opportunity .
Not much else Markku can say .
Just need to hang in there . If you believe , like they do , that it works , then just sit back and wait for the good news .

It would have to be a set of 3 coins - one for each mine obviously .

Huge Steak Building sauce more like .
C'mon , 3 more pennies and I'm in the blue .
Is it really that crucial in the scheme of things that I always have to be in the red ?

Took advantage of a little glitch there with the bid higher than the ask , and moved some shares into my ISA. Not often that happens so appreciated.

Had a couple of chunks in the 50's , so have taken advantage . Average was about 180p before that . It's only a mental barrier really . Its not like I'd sell at 150p now , so close to an update .

Why is 132p so hard to crack ? It's like the share Gods know its my average buy price , and just don't want me to feel like a success .

Imagine three Titanic ships laid end to end upright in a hole , and you'd still be over 100m shorter than the Hav footprint (so far) . The scale of this beast is just breathtaking .

Looks like we're off the starting line .
Great news .
I know this seems to have taken ages , but I think in reality to get a first dosing in a 'new' area like this , is quite an achievement for the team .
Good luck to them and the patients - potential to make a real difference here .

And results can bee seen ' very soon' we are told , due to the nature of the treatment .

"You sold. That usually sends the price down. But on this board I wonder if people actually know how markets work."

How many shares do I think I own haha ??

Taps head - hears hollow ringing noise lol

It was only a few grand , just took an extra few in the low 10's to try and make a quick turnaround .
So in that respect it worked .
And overall , the main pot has gone up so it's all good .

Lets hope it continues .
Only fly in the ointment for me was that I sold my trading pot on Friday for 11.6p .
Don't get greedy they said lol .
I like to think I've taken one for the team there in order for the SP to continue upwards .

Its 11.35p at the moment . I've changed my mind . 12p or nothing